|
全民健康保險藥品給付規定 |
|
See related Isentress film-coated tab[宜昇瑞 膜衣錠] information |
|
|
|
製造商 |
Merck Sharp & Dohme |
|
代理/經銷商 |
Merck Sharp & Dohme |
|
成份 |
Raltegravir |
|
適應症 |
In combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy. |
|
用量 |
400 mg bid. |
|
過量 |
View Isentress[宜昇瑞] overdosage for action to be taken in the event of an overdose. |
|
用法 |
May be taken with or without food |
|
美國食品藥物管理局之懷孕等級 |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
禁忌 |
[Click for Isentress[宜昇瑞] detailed prescribing infomation] |
|
注意事項 |
Immune reconstitution syndrome. Elderly ≥65 yr. Pregnancy & lactation. |
|
不良反應 |
Diarrhea, nausea, headache. Vertigo, abdominal pain, flatulence, constipation. Asthenia, fatigue. Arthralgia, dizziness, lipodystrophy acquired, rash, hyperhidrosis.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
|
交互作用 |
Rifampin, atazanavir.
View more drug interactions with Isentress[宜昇瑞] |
|
儲存 |
View Isentress[宜昇瑞] storage conditions for details to ensure optimal shelf-life. |
|
描述 |
View Isentress[宜昇瑞] description for details of the chemical structure and excipients (inactive components). |
|
作用 |
View Isentress[宜昇瑞] mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
本商品之市售規格 |
|
|
|
Manufacturer: |
Merck Sharp & Dohme |
|
Distributor: |
Merck Sharp & Dohme
|
|
|
|
